Operator: Good afternoon, and welcome to Lumos Pharma s Q2 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Operator: Good afternoon, and welcome to Lumos Pharma s 2022 Financial Results Conference Call. We ll now turn the call over to Lisa Miller, Senior Director of Investor Relations.
Interim Data for Potentially the First Oral Medication for PGHD from Phase 2 OraGrowtH210 and PK/PD OraGrowtH212 Trials Met Expectations with an Encouraging Growth Response of 8.6 cm/yr at six. | November 14, 2022
CHICAGO — A small pilot program improved the wellness and work productivity of expectant and new physician parents by offering them coaching sessions and stipends for lactation support, a recent study found.
Speaking to Healio, lead author Josephine Li, MD, an endocrinologist in the diabetes unit at Massachusetts General Hospital, and senior author Laura Dichtel, MD, an assistant professor
Growth hormone improves liver health in patients with nonalcoholic fatty liver disease (NAFLD) by reducing liver fat and inflammation, according to a new study presented Tuesday, June 14 at ENDO 2022,.